pipette
ESEspañol

Plasma eMTBR-tau as a robust biomarker for Alzheimer's disease tangle pathology up to 10 years before death

R. Shi, X. Zeng, M. F. Farinas, M. N. Nafash, D. S. Smirnov, M. I. Kamboh, B. Snitz, J. K. Kofler, A. D. Cohen, T. A. Pascoal, M. D. Ikonomovic, H. Zetterberg, O. Lopez, T. K. Karikari

PreprintReal-world use

In the authors' words

Scalable and accessible biomarkers of neurofibrillary tangle pathology are needed for Alzheimer's disease prognosis, diagnosis and monitoring. Here, we show that a blood-based immunoassay for an endogenously-cleaved eMTBR-tau fragment of tau protein is strongly associated with autopsy-diagnosed Alzheimer neuropathologic change (ADNC) and predominantly reflects the burden and anatomical progression of tangle pathology but not amyloid plaque load despite being most elevated in amyloid-positive symptomatic individuals. Plasma eMTBR-tau was significantly more accurate than plasma p-tau217 in classifying Braak staging and ADNC statuses at autopsy. Importantly, neuropathologic classification by plasma eMTBR-tau remained high (AUC=0.91-0.95) even when increasing intervals between blood collection and death up to a decade, while maintaining superior sensitivity and specificity over p-tau217. Higher baseline plasma eMTBR-tau was associated with worse cognition cross-sectionally and longitudinally predicted faster worsening. These results were replicated in a living cohort with in vivo tangle and plaque neuroimaging. Plasma eMTBR-tau concordance with tau neuroimaging was up to 94%, suggesting surrogacy. Together, plasma eMTBR-tau captures biological signatures of Braak staging and ADNC over a prolonged pre-mortem window, highlighting potential for early disease detection, biological staging, prognosis and therapeutic development.

Main resultThe abstract does not state a limitation.

In plain words AI summary

The researchers developed a blood test that measures a specific fragment of tau protein called eMTBR-tau. This blood marker matched brain autopsy findings of Alzheimer's tangle damage better than another common test called p-tau217. Higher levels of this marker predicted faster decline in thinking and memory over time. The results suggest this blood test could help detect Alzheimer's early and track its progression.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source. 1 sentence was removed for not being supported by the abstract.

Appeared: Tuesday, October 6. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.09.29.26363951